Updated thresholds outperform those recommended by American Thyroid Association guidelines for patients with medullary thyroid cancer.

Caprelsa® (vandetanib) is a medicine that is used in adults and children above 5 years of age to treat aggressive and symptomatic medullary thyroid cancer 1. This is a new step forward in ESTEVE ...

Medullary thyroid carcinoma is a type of cancer that starts in the cells in the thyroid gland that produces the hormone calcitonin.

Thyroid. 2003;13 (1) Follow-up of Patients with Deferred FNA The follow-up frequency (i.e. every 6 to 24 months) should be appropriate for the degree of diagnostic certainty that the nodule is benign.